- |||||||||| Trial completion, Enrollment change: MicroRNA Diagnostics in Subarachnoid Hemorrhage 2 (clinicaltrials.gov) - May 27, 2015
P=N/A, N=70, Completed, Active, not recruiting --> Completed | Phase classification: P3 --> PN/A Recruiting --> Completed | N=50 --> 70
- |||||||||| Enrollment closed, Trial primary completion date: Anti-MERS-CoV Convalescent Plasma Therapy (clinicaltrials.gov) - Apr 15, 2015
P2, N=20, Active, not recruiting, Initiation date: Jan 2015 --> Apr 2015 | Trial primary completion date: Mar 2016 --> Mar 2017 Not yet recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> May 2017
- |||||||||| Trial primary completion date: LIPS-B: Lung Injury Prevention Study With Budesonide and Beta (clinicaltrials.gov) - Apr 14, 2015
P2, N=60, Recruiting, Not yet recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> May 2017 Trial primary completion date: Jan 2015 --> Jul 2015
- |||||||||| Enrollment change, Trial primary completion date: Early Rehabilitation of COPD Patients in ICU (clinicaltrials.gov) - Mar 27, 2015
P=N/A, N=5, Terminated, Phase classification: P2 --> P3 N=240 --> 5 | Trial primary completion date: Mar 2013 --> Nov 2008
- |||||||||| ketamine / Generic mfg.
Enrollment closed, Trial primary completion date: Pharmacokinetic Alterations During ECMO (clinicaltrials.gov) - Feb 27, 2015 P=N/A, N=20, Active, not recruiting, N=28 --> 0 Recruiting --> Active, not recruiting | Trial primary completion date: May 2014 --> Feb 2015
|